Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Coping with chemoresistance in prostate cancer-co-targeting of adipose stromal cells?

Bhagirath D, Saini S.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S250-S253. doi: 10.21037/tau.2019.01.03. No abstract available.

2.

BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2.

Bhagirath D, Yang TL, Tabatabai ZL, Majid S, Dahiya R, Tanaka Y, Saini S.

Clin Cancer Res. 2019 Aug 1. doi: 10.1158/1078-0432.CCR-19-0498. [Epub ahead of print]

PMID:
31371344
3.

Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression.

Bhagirath D, Yang TL, Tabatabai ZL, Shahryari V, Majid S, Dahiya R, Tanaka Y, Saini S.

Carcinogenesis. 2019 Jul 4;40(5):633-642. doi: 10.1093/carcin/bgz058.

PMID:
30874288
4.

MicroRNAs as Regulators of Prostate Cancer Metastasis.

Bhagirath D, Yang TL, Dahiya R, Saini S.

Adv Exp Med Biol. 2018;1095:83-100. doi: 10.1007/978-3-319-95693-0_5. Review.

PMID:
30229550
5.

microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.

Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S.

Cancer Res. 2018 Apr 1;78(7):1833-1844. doi: 10.1158/0008-5472.CAN-17-2069. Epub 2018 Feb 1.

6.

A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.

Bucay N, Bhagirath D, Sekhon K, Yang T, Fukuhara S, Majid S, Shahryari V, Tabatabai Z, Greene KL, Hashimoto Y, Shiina M, Yamamura S, Tanaka Y, Deng G, Dahiya R, Saini S.

Cell Death Differ. 2017 Jul;24(7):1263-1274. doi: 10.1038/cdd.2017.69. Epub 2017 May 12.

7.

Mutant PIK3CA Induces EMT in a Cell Type Specific Manner.

Bhagirath D, Zhao X, Mirza S, West WW, Band H, Band V.

PLoS One. 2016 Dec 12;11(12):e0167064. doi: 10.1371/journal.pone.0167064. eCollection 2016.

8.

Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.

Bhagirath D, Zhao X, West WW, Qiu F, Band H, Band V.

Oncotarget. 2015 Apr 20;6(11):9018-30.

9.

Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.

Bhagirath D, Abrol N, Khan R, Sharma M, Seth A, Sharma A.

Clin Chim Acta. 2012 Oct 9;413(19-20):1641-6. doi: 10.1016/j.cca.2012.05.005. Epub 2012 May 14.

PMID:
22626996

Supplemental Content

Loading ...
Support Center